SVP Clinical Development Jeffrey Wiezorek sold $1.0M of Kite Pharma, Inc.

Sold$1,043,201

$104.32Price

10,000Shares

−32%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Jul 3. Filed Thu, Jul 6, 2:15 PM ET, during the session. Not investment advice.